Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DMC Biotechnologies
AddedFeb 15, 2024
UpdatedJun 18, 2026
DMC Biotechnologies

DMC Biotechnologies

Series B

DMC Biotechnologies: A US-based biotech firm specializing in bio-based chemical production for diverse industries.

HQ
Boulder, CO, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

DMC Biotechnologies, founded with the mission to revolutionize chemical production through sustainable methods, focuses on bio-based chemical production. The company leverages its proprietary synthetic metabolic valve technology to engineer microbial hosts for producing a wide range of specialty chemicals, including flavors, fragrances, nutraceuticals, and natural products. DMC aims to provide a cost-effective and environmentally-friendly alternative to traditional chemical manufacturing, primarily serving the U.S. market.

Notable figures associated with DMC Biotechnologies include its founders and key investors who have supported the company's innovative approach to sustainable chemistry. The company has achieved significant milestones, such as demonstrating the scalability and economic viability of its technology platform. DMC's impact is evident in its contribution to more sustainable industrial practices and its potential to transform the chemical production industry by reducing reliance on fossil fuels and lowering environmental footprints.

DMC Biotechnologies - Similar Companies

Capra Biosciences logo

Capra Biosciences

Zymochem logo

Zymochem

zymochem.com

Lygos logo

Lygos

lygos.com

Genomatica logo

Genomatica

genomatica.com

BiotecEra logo

BiotecEra

biotecera.com

Modular Genetics logo

Modular Genetics

Wild Microbes logo

Wild Microbes

wildmicrobes.com

Microvi Biotech logo

Microvi Biotech

Solugen logo

Solugen

solugen.com

OmegaChea logo

OmegaChea

Varifas Biorenewables logo

Varifas Biorenewables

Conagen logo

Conagen

DoubleRainbow Biosciences logo

DoubleRainbow Biosciences

Biomade logo

Biomade

Twist Bioscience logo

Twist Bioscience

DMC Biotechnologies - Quick Facts

Who are DMC Biotechnologies' competitors?

Companies similar to DMC Biotechnologies include Capra Biosciences, Zymochem, Lygos and Genomatica.

When was DMC Biotechnologies founded?

DMC Biotechnologies was founded in 2014.

Where is DMC Biotechnologies' headquarters located?

DMC Biotechnologies' headquarters is located in Boulder, CO, US.

When was DMC Biotechnologies' last funding round?

DMC Biotechnologies' most recent funding round was for $39M (USD) in December 2021.

How much has DMC Biotechnologies raised to-date?

As of Dec 2, 2021, DMC Biotechnologies has raised a total of $53M (USD).

How many employees does DMC Biotechnologies have?

DMC Biotechnologies has 47 employees as of Feb 5, 2024.

DMC Biotechnologies - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Bio-Based Chemicals
Tags
  • Cleantech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified